It looks like you're new here. If you want to get involved, click one of these buttons!
......Sounds like a very common reaction from years ago on this Board re: The Zurich Axioms: complaints about the Axioms containing contradictory observations and advice, making them virtually useless. I think the response here from @FD1000 illustrates perfectly the fact that we are all put together differently. We confront the world from different perspectives, operating with very different assumptions, fundamentally. Our various approaches to making sense of things will be different. My own reply is simple: investing is not a cut-and-dried process, like following a recipe. If that's the way one invests, I assert that it must be a method arrived at after much PRIOR investigation and analysis. Because not only the Markets, but the entire world, is a jumble of contradictory signals and noise and extraneous incidentals. Each of us must sort it all out for ourselves. I am very much in touch with the line of thought which says that investing is always some combination of both Science and Art. Very little in this life is all-or-nothing, either/or, or black or white. It's complicated. Anything which is important enough to matter is complicated.Concur with LB.
More, I read many of Marks articles over the years and they are long. Lots of fluff with contradicting reasons of what to do and what not. The end result is hardly any specifics of what to do and when.
I have heard the above many times. Why stop at foreign-domiciled companies? Why not slice it 8 ways, just to be sure. This is why many investors lag by complicating their portfolios. The fact is that the most dominated companies are in the SP500 + the USA is very stable + capitalism is not perfect, but still the best we have + I prefer American management globally. China high tech looked great until Xi Jinping took care of that. Europe have been sinking for years. Did you know that there is no European high-tech company by revenue at the topGood post. The longer you check, and I'm talking about at least 20-30 years, a cheap index such as the SP500 beats most stock funds.
The SP500 is based on the best indicator, the price. The price never lies, regardless of any opinion.
The SP500 is global too, it gets about 40% of its revenues from abroad.
The S&P 500 index is a good representation of large-cap U.S. stocks.
Most active funds underperform this index over longer time periods.
Although many S&P 500 companies derive substantial revenue from foreign countries,
it may be prudent to also include foreign-domiciled companies in your portfolio.
I respect Warren Buffett and Jack Bogle but disagree with their views to avoid foreign investments.
The S&P 500 index is a good representation of large-cap U.S. stocks.Good post. The longer you check, and I'm talking about at least 20-30 years, a cheap index such as the SP500 beats most stock funds.
The SP500 is based on the best indicator, the price. The price never lies, regardless of any opinion.
The SP500 is global too, it gets about 40% of its revenues from abroad.
Yeah, That’s a tough nut to crack. I have a little diversified EM at Dodge & Cox. Blind faith I guess in their stewardship. And a very small hold in ENOR (Norway) which is actually in my Real Assets sleeve due to its economy’s heavy dependence on energy exports. Neither of the aforementioned funds, however, is “shooting the lights out.” In fact I’d liken it more to shooting myself in the foot.I have no idea how to make geographical sector bets so personally I wouldn't use any non-diversified EM fund myself, especially as a buy and hold fund.
Two years later it is quite the opposite now with rising interest rate and that put considerable pressure on tech stocks.At the time, interest rates were near zero, tech companies were expanding, and Americans had extra cash thanks to stimulus checks from the federal government.
What are the 5% of health care fund peers who have made more than 50% annualized over the last six years? Or is this "outperforming 95% of peers" just a made up figure to make it seems that the 50% returns reported are not equally fictitious?Outperformed 95% of peers over the last six years with less risk.
...
Long-tenured advisors of three PhDs and one MD in internal medicine
© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla